object
novel
coronaviru
declar
public
health
emerg
worldwid
object
systemat
review
character
clinic
diagnost
treatment
characterist
patient
present
introduct
late
decemb
earli
januari
report
progress
pneumonialik
respiratori
syndrom
start
wuhan
china
induc
global
health
concern
soon
onset
diseas
found
pathogen
new
member
coronavirida
famili
name
call
respiratori
syndrom
caus
call
character
lowgrad
fever
cough
dyspnea
lymphopenia
groundglass
opac
chest
ct
scan
highli
contagi
diseas
probabl
aerosol
born
one
human
human
transmiss
capac
implic
mani
countri
around
world
review
articl
systemat
survey
case
report
case
seri
mani
countri
world
give
pictur
epidemiolog
clinic
present
laboratori
chang
imag
find
diagnost
criteria
treatment
outcom
prognost
factor
risk
factor
covid
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
illustr
figur
systemat
search
result
initi
number
potenti
relev
articl
exclud
titl
abstract
evalu
appli
inclusionexclus
criteria
fulltext
document
articl
elig
inclus
systemat
review
asymptomat
transfer
lead
lower
preval
estim
higher
transmiss
rate
commun
univers
screen
vaccin
becom
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
avail
necessari
trace
close
contact
test
posit
quarantin
contact
prevent
asymptomat
transmiss
accord
articl
includ
transfer
person
person
chen
et
al
suggest
evid
vertic
transmiss
mother
child
person
infect
develop
clinic
cours
howev
report
caus
sever
symptom
respiratori
failur
older
men
comorbid
children
teenag
younger
peopl
mostli
show
mild
present
diseas
base
review
articl
hypertens
diabet
cardiovascular
diseas
pulmonari
diseas
common
morbid
among
patient
point
also
mention
alraddadi
et
al
studi
merscov
patient
show
individu
comorbid
like
diabet
smoke
cardiovascular
diseas
associ
sever
clinic
cours
accord
yang
et
al
chronic
diseas
debilit
immun
system
make
proinflammatori
condit
lead
sever
infect
subsequ
higher
mortal
rate
accord
includ
studi
common
clinic
manifest
fever
cough
dyspnea
myalgia
fatigu
less
common
clinic
manifest
includ
nausea
vomit
dizzi
rhinorrhea
chill
liu
et
al
report
infant
mild
clinic
manifest
better
prognosi
furthermor
asymptomat
case
seen
among
children
common
abnorm
laboratori
chang
lymphopenia
high
concentr
reactiv
protein
elev
level
aspart
aminotransferas
howev
know
exact
pathogenesi
reason
alter
laboratori
abnorm
may
indic
sever
diseas
develop
complic
accord
huang
et
al
patient
secondari
infect
procalcitonin
level
greater
ngml
icu
patient
higher
level
prothrombin
time
ddimer
also
liu
et
al
mention
use
hypoalbuminemia
lymphopenia
high
concentr
crp
elev
ldh
predict
sever
acut
lung
injuri
higher
level
angiotensin
ii
also
propos
relat
acut
lung
injuri
meanwhil
nonsurvivor
suggest
higher
ddimer
fdp
level
longer
pt
aptt
lower
fibrinogen
antithrombin
level
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ct
scan
diagnost
tool
use
evalu
sever
pulmonari
involv
monitor
clinic
progress
ct
scan
good
sensit
use
establish
diagnosi
patient
highli
suspici
base
epidemiolog
histori
clinic
manifest
neg
pcrbase
test
result
import
highlight
ct
scan
normal
initi
day
normal
ct
scan
suspect
case
would
never
definit
rule
diagnosi
moreov
ct
scan
dynam
patient
chang
rapidli
earliest
abnorm
find
ct
scan
appear
groundglass
opac
peripher
subpleur
area
diseas
progress
ggo
expand
distribut
commonli
right
lower
lung
lobe
later
find
includ
consolid
pave
pattern
thicken
lobar
fissur
adjac
pleura
pleural
effus
hilar
lymphadenopathi
mediastin
lymphadenopathi
common
find
report
scarc
lung
patholog
progress
white
lung
low
function
capac
heal
fibrot
remnant
dynam
chang
lung
seen
ct
imag
continu
even
patient
discharg
complic
acut
cardiac
injuri
acut
kidney
injuri
secondari
infect
shock
lead
multipl
organ
failur
icu
patient
comparison
nonicu
patient
also
like
complic
mortal
rate
higher
critic
ill
patient
well
older
patient
comorbid
ard
yang
et
al
report
median
durat
icu
admiss
death
day
window
present
time
icu
admiss
andor
develop
ard
optim
time
medic
intervent
mani
challeng
therapeut
strategi
current
cure
howev
pharmacolog
nonpharmacolog
symptom
manag
support
care
measur
given
patient
symptomat
variou
therapeut
strategi
trial
patient
goal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
slow
diseas
progress
pauciti
data
surround
efficaci
treatment
case
control
case
seri
includ
antivir
agent
includ
hiv
proteas
inhibitor
lopinavir
ritonavir
well
antiinfluenza
compound
oseltamivir
arbidol
use
treatment
regimen
unfortun
nt
enough
inform
efficaci
regimen
howev
accord
studi
antihiv
base
medic
could
benefit
rapid
improv
clinic
manifest
decreas
viral
load
conclus
discuss
clinic
symptom
laboratori
abnorm
common
comorbid
imag
modal
potenti
therapeut
option
indic
common
symptom
fever
cough
dyspnea
young
infect
case
sign
symptom
ard
common
report
complic
associ
poor
prognosi
wake
pandem
countri
scrambl
produc
enough
rtpcr
diagnost
test
diagnost
inform
surrog
marker
would
valuabl
marker
prove
sensit
specif
name
learn
laboratori
data
like
crp
may
relat
sever
diseas
may
predict
diseas
outcom
studi
need
relat
quantifi
elev
crp
diseas
sever
due
high
sensit
ct
scan
consid
good
diagnost
tool
howev
kept
mind
normal
ct
scan
never
rule
diagnosi
highli
suspici
case
base
histori
clinic
find
lastli
differ
therapeut
strategi
patient
nt
enough
data
efficaci
addit
investig
includ
random
control
trial
necessari
understand
treatment
covid
copyright
holder
preprint
yingchu
liu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
roth
c
et
al
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
